Dr. Stefan C. Weiss Joins SFA Therapeutics as Chief Medical Officer
Stefan C. Weiss, MD, MBA, is now the Chief Medical Officer at SFA Therapeutics, Inc. a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for the treatment of inflammatory diseases. SFA’s lead asset, SFA-002, is approaching Phase 2 clinical trials and has shown promising Phase 1a and Phase 1b results for the treatment of psoriasis. Most […]